MKI67 and prostate cancer: It is possible that the MAG-EPA intervention could have reduced the Ki-67 index if performed in a population of prostate cancer patients with higher omega-6 and lower omega-3 intake, which presumably would have had a higher baseline prostate cancer proliferative rate.